Skip to main content
NCD 110.13 · version 1

NCD 110.13: Cytotoxic Food Tests

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 110.13

Benefit category
Diagnostic Tests (other)
Effective date
08/05/1985
Transmittal
Transmittal 1
Versions published
1
Manual section
110
Hematology/Immunology/Oncology, NCD Manual (Pub. 100-03) chapter 1 part 2

TL;DR

NCD 110.13 sets Medicare's national policy for cytotoxic food tests under the benefit category "Diagnostic Tests (other)", effective 08/05/1985. Prior to August 5, l985, Medicare covered cytotoxic food tests as an adjunct to in vivo clinical allergy tests in complex food allergy problems. Effective August 5, l985, cytotoxic leukocyte tests for food allergies are excluded from Medicare coverage because… It has been revised once since publication and binds every Medicare Administrative Contractor nationally.

Indications and limitations of coverage

Prior to August 5, l985, Medicare covered cytotoxic food tests as an adjunct to in vivo clinical allergy tests in complex food allergy problems. Effective August 5, l985, cytotoxic leukocyte tests for food allergies are excluded from Medicare coverage because available evidence does not show that these tests are safe and effective. This exclusion was published as a CMS Ruling in the "Federal Register" on July 5, l985.

Text reproduced from the CMS Medicare Coverage Database record for NCD 110.13 version 1. View the original on cms.gov.

Local policies that build on this NCD

3 active Local Coverage Determinations cite NCD 110.13 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

  • Allergy Testing (L36241) · Novitas Solutions, Inc.
  • L33261 Allergy Testing · First Coast Service Options, Inc.
  • L33591 RAST Type Tests · Wellpoint Federal

How MACs bill NCD 110.13

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 1 current article in the Medicare Coverage Database names NCD 110.13, 1 of them with a covered ICD-10-CM list, from 1 contractor. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

Contractors with articles that implement NCD 110.13
ContractorArticles
Wellpoint FederalA56844

A56844: Billing and Coding: RAST Type Tests

Billing and Coding, effective 2026-04-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record

1,008 covered ICD-10-CM codes; 4 procedure codes: 86001, 86003, 86005, 86008. Local policy: L33591 RAST Type Tests. Check a diagnosis for 86001.

First covered codes: J30.0 Vasomotor rhinitis; J30.1 Allergic rhinitis due to pollen; J30.2 Other seasonal allergic rhinitis; J30.5 Allergic rhinitis due to food; J30.81 Allergic rhinitis due to animal (cat) (dog) hair and dander; J30.89 Other allergic rhinitis; …

Revision history

11/1985 - Stated that cytotoxic leukocyte testing for food allergies not covered. Effective date 08/05/1985. (TN 1)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 110.13

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 110.13

What does NCD 110.13 cover?

Prior to August 5, l985, Medicare covered cytotoxic food tests as an adjunct to in vivo clinical allergy tests in complex food allergy problems. Effective August 5, l985, cytotoxic leukocyte tests for food allergies are excluded from Medicare coverage because available evidence does not show that these tests are safe and effective. This exclusion was published as a CMS Ruling in the "Federal Register" on July 5… The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 110.13 take effect?

The current version (1) is effective 08/05/1985, published in transmittal 1. This is the only published version.

Does a Local Coverage Determination override NCD 110.13?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.